Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

Study identifier:NIS-CSG-CRE-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects with Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings

Medical condition

hypercholesterolaemia

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

800

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Aug 2010

Primary Completion Date: 01 Dec 2010

Study Completion Date: 01 Dec 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

CSR-NIS-CSG-CRE-2011-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Investigators

Principal Investigator

DR ARTHUR TAN

ARTHUR TAN HEART CLINIC, GLENEAGLES MEDICAL CENTRE